Considerations for conducting meta-analysis in diagnostic pathology

Archives of Pathology and Laboratory Medicine

Volumn 139, Issue 11, 2015, Pages 1331-

  Mayo, Erin ^a   Kinzler, Michael ^b   Zhang, Lanjing ^c,d  

^a RUTGERS SCHOOL OF PUBLIC HEALTH   (United States)

^b Center for Language and Brain   (United States)

^c University Medical Centre Princeton   (United States)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EVIDENCE BASED MEDICINE; HUMAN; LITERATURE; PATHOLOGY; PRACTICE GUIDELINE;

EVIDENCE-BASED MEDICINE; HUMANS; PATHOLOGY, CLINICAL; PRACTICE GUIDELINES AS TOPIC; REVIEW LITERATURE AS TOPIC;

EID: 84945927799     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2015-0064-LE     Document Type: Letter

References (5)

1. Marchevsky AM, Wick MR. Evidence-based pathology: Systematic literature reviews as the basis for guidelines and best practices [published online ahead of print October 30, 2014]. Arch Pathol Lab Med. 2015; 139 (3): 394-399. doi: 10.5858/arpa. 2014-0106-RA.
2. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-Analyses: The PRISMA statement. PLoS Med. 2009; 6 (7): E1000097.
3. Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and metaanalysis protocols (PRISMA-P) 2015: Elaboration and explanation. BMJ. 2015; 349: G7647.
4. Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-Analyses. Ottawa, ON: Department of Epidemiology and Community Medicine, University of Ottawa; 2011. www.ohri.ca/programs/clinical-epidemiology/oxford.asp. Accessed April 1, 2015.
5. Kinzler M, Zhang L. Underutilization of metaanalysis in diagnostic pathology. Arch Pathol Lab Med. 2015; 139 (10): 1302-1307.